A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC

CompletedOBSERVATIONAL

Enrollment

160

Participants

Timeline

Start Date

January 26, 2016

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions

Castration Resistant Prostate Cancer (CRPC)

All Listed Sponsors

lead

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

OTHER

NCT02669147 - A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC | Biotech Hunter | Biotech Hunter